Share on

Eastern Europe Biopharmaceuticals Market By Product Type (Monoclonal Antibodies (mAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-stimulating Factor (G-CSF), Interferon And Human Growth Hormones (HGH)) By Therapeutic Type (Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular And Other Therapeutic Areas), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

Pulished: October, 2018

ID: 7502

Pages: 180

The Eastern Europe Biopharmaceuticals market was worth $XX billion in 2018 and estimated to be growing at a CAGR of XX%, to reach $XX billion by 2023.

Development of biopharmaceutical product is being undertaken by increasing number of competitors in the pharmaceutical industry. Market players are more focusing on expanding the biologics pipeline, relying on the fact that commercialization of biopharmaceuticals will reduce the usage of traditional small molecular drugs. Pharmaceutical industries mainly rely on biopharmaceuticals for profits and innovation.

Advancement in biomedical science holds vast potential for the growth of biopharmaceuticals market. Ability of these drugs to treat chronic diseases which were earlier untreatable is increasing its demand enormously and also increases the profit margin for manufacturers. Biopharmaceutical drugs need to be stored in cold storage which limits their transport to rural areas and hence hindering the growth of the market.

The Eastern Europe biopharmaceuticals market is segmented on the basis of products into Monoclonal Antibodies (mAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte colony-stimulating factor (G-CSF), Interferon and Human growth hormones (HGH). Monoclonal antibodies segment holds the highest number of shares in the product sector. Based on therapeutics, the market is bifurcated into Neurology, Infectious diseases, Diabetes, Oncology, Cardiovascular and other therapeutic areas. In terms of therapeutic application, oncology is the largest segment in the biopharmaceuticals market.

Based on geography the market is analyzed under various countries namely, Ukraine, Poland, Romania, Czech Republic, Hungary and Rest of Eastern Europe

Merck & Co., Inc., F. Hoffmann-La Roche AG, Eli Lilly and Company, Inc., Sanofi, Amgen Inc., AbbVie Inc., Biogen Idec, Bayer AG, Johnson & Johnson Services, Pfizer, Inc., and Novartis AG are some of the leading players in the market for biopharmaceuticals.

1. Introduction

1.1 Market Definition

1.2 Study Deliverables

1.3 Base Currency, Base Year and Forecast Periods

1.4 General Study Assumptions

2. Research Methodology

2.1 Introduction

2.2 Research Phases

2.2.1 Secondary Research

2.2.2 Primary Research

2.2.3 Econometric Modelling

2.2.4 Expert Validation

2.3 Analysis Design

2.4 Study Timeline

3. Overview

3.1 Executive Summary

3.2 Key Inferences

3.3 New Developments

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

4.1 Market Drivers

4.2 Market Restraints

4.3 Key Challenges

4.4 Current Opportunities in the Market

5. Market Segmentation

5.1 By Product Type

5.1.1 Monoclonal Antibodies (mAb)

5.1.2 Erythropoietin

5.1.3 Biotech Vaccines

5.1.4 Recombinant Human (RH) Insulin

5.1.5 Granulocyte colony-stimulating factor (G-CSF)

5.1.6 Interferon

5.1.7 Human growth hormones (HGH)

5.2 By Therapeutic Type

5.2.1 Neurology

5.2.2 Infectious diseases

5.2.3 Diabetes

5.2.4 Oncology

5.2.5 Cardiovascular

5.2.6 Other Therapeutic Areas

6. Geographical Analysis

6.1 Introduction

6.2 Ukraine

6.3 Poland

6.4 Romania

6.5 Czech Republic

6.6 Hungary

6.7 Rest of Eastern Europe

7. Strategic Analysis

7.1 PESTLE analysis

7.1.1 Political

7.1.2 Economic

7.1.3 Social

7.1.4 Technological

7.1.5 Legal

7.1.6 Environmental

7.2 Porter’s Five analysis

7.2.1 Bargaining Power of Suppliers

7.2.2 Bargaining Power of Consumers

7.2.3 Threat of New Entrants

7.2.4 Threat of Substitute Products and Services

7.2.5 Competitive Rivalry within the Industry

8. Market Leaders' Analysis

8.1 Merck & Co.

8.1.1 Overview

8.1.2 Product Analysis

8.1.3 Strategic Evaluation and Operations

8.1.4 Financial analysis

8.1.5 Legal issues

8.1.6 Recent Developments

8.1.7 SWOT analysis

8.1.8 Analyst View

8.2 F. Hoffmann-La Roche AG

8.3 Eli Lilly and Company

8.4 Sanofi

8.5 Amgen Inc.

8.6 AbbVie Inc.

8.7 Biogen Idec

8.8 Bayer AG

8.9 Johnson & Johnson Services

8.10 Pfizer

8.11 Novartis AG

9. Competitive Landscape

9.1 Market share analysis

9.2 Merger and Acquisition Analysis

9.3 Agreements, collaborations and Joint Ventures

9.4 New Product Launches

10. Expert Opinions

10.1 Market Outlook

10.2 Investment Opportunities

Appendix

a) List of Tables

b) List of Figures

Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

1. Eastern Europe Biopharmaceuticals Market By Region, From 2018-2023 (USD Billion)

2. Eastern Europe Biopharmaceuticals Market By Product Type, From 2018-2023 (USD Billion)

3. Eastern Europe Monoclonal Antibodies (mAb) Market By Region, From 2018-2023 (USD Billion)

4. Eastern Europe Erythropoietin Market By Region, From 2018-2023 (USD Billion)

5. Eastern Europe Biotech Vaccines Market By Region, From 2018-2023 (USD Billion)

6. Eastern Europe Recombinant Human (RH) Insulin Market By Region, From 2018-2023 (USD Billion)

7. Eastern Europe Granulocyte colony-stimulating factor (G-CSF) Market By Region, From 2018-2023 (USD Billion)

8. Eastern Europe Interferon Market By Region, From 2018-2023 (USD Billion)

9. Eastern Europe Human growth hormones (HGH) Market By Region, From 2018-2023 (USD Billion)

10. Eastern Europe Biopharmaceuticals Market By Therapeutic Type, From 2018-2023 (USD Billion)

11. Eastern Europe Neurology Market By Region, From 2018-2023 (USD Billion)

12. Eastern Europe Infectious diseases Market By Region, From 2018-2023 (USD Billion)

13. Eastern Europe Diabetes Market By Region, From 2018-2023 (USD Billion)

14. Eastern Europe Oncology Market By Region, From 2018-2023 (USD Billion)

15. Eastern Europe Cardiovascular Market By Region, From 2018-2023 (USD Billion)

16. Eastern Europe Other Therapeutic Areas Market By Region, From 2018-2023 (USD Billion)

17. Ukraine Biopharmaceuticals Market By Product Type, From 2018-2023 (USD Billion)

18. Ukraine Biopharmaceuticals Market By Therapeutic Type, From 2018-2023 (USD Billion)

19. Poland Biopharmaceuticals Market By Product Type, From 2018-2023 (USD Billion)

20. Poland Biopharmaceuticals Market By Therapeutic Type, From 2018-2023 (USD Billion)

21. Hungary Biopharmaceuticals Market By Product Type, From 2018-2023 (USD Billion)

22. Hungary Biopharmaceuticals Market By Therapeutic Type, From 2018-2023 (USD Billion)

23. Romania Biopharmaceuticals Market By Product Type, From 2018-2023 (USD Billion)

24. Romania Biopharmaceuticals Market By Therapeutic Type, From 2018-2023 (USD Billion)

25. Czech Republic Biopharmaceuticals Market By Product Type, From 2018-2023 (USD Billion)

26. Czech Republic Biopharmaceuticals Market By Therapeutic Type, From 2018-2023 (USD Billion)

LICENCE TYPE

~~$ 1234~~ 3335

Add to Cart

Not ready to buy yet

Research Reports

LICENCE TYPE

Clients

Research Areas

Reports By Region

Reports By Industry